US FDA approves nasal spray for migraines
The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.. "As a nasal spray with rapid drug absorption, Zavzpret offers an alternative treatment option for people who need pain relief or cannot take oral medications due to nausea or vomiting," Pfizer quoted Kathleen Mullin, associate medical director at the New England Institute for Neurology and Headache, as saying.